Sanofi Agreement (Additional Information) (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
May 31, 2022 |
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||
| Deferred Revenue | $ 0 | $ 145,050 | $ 0 | $ 145,050 | $ 144,122 | $ 146,801 | |
| Contract asset | 0 | 0 | 0 | ||||
| Sanofi Agreement [Member] | |||||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||||
| Deferred Revenue | 0 | 0 | 144,100 | ||||
| Deferred revenue recognized | 143,600 | ||||||
| Deferred revenue, Current | $ 2,700 | ||||||
| Revenues | $ 143,600 | $ 1,300 | 144,100 | $ 1,800 | |||
| Adjustment of collaboration revenue | 800 | ||||||
| Revenue Transaction Price | 150,000 | ||||||
| Upfront payment received | $ 150,000 | ||||||
| Development And Regulatory Milestones Exchange | $ 1,065,000 | ||||||
| X | ||||||||||
- Definition Adjustment of Collaboration Revenue No definition available.
|
| X | ||||||||||
- Definition Development and regulatory milestones exchange No definition available.
|
| X | ||||||||||
- Definition Revenue Transaction Price No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of revenue recognized that was previously reported as deferred or unearned revenue. No definition available.
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|